Corbus Pharmaceuticals Holdings, Inc. SEC filings CRBP
Corbus Pharmaceuticals Holdings, Inc. has 808 filings in SEC EDGAR's recent list, going back to Jan 10, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | Apr 1, 2026 |
| DEFA14A | Additional proxy material | Apr 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| DEF 14A | Proxy statement | Apr 2, 2024 | Mar 29, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | May 16, 2024 |
| DEF 14A | Proxy statement | Apr 3, 2023 | — |
| DEFA14A | Additional proxy material | Apr 3, 2023 | — |
| DEF 14A | Proxy statement | Nov 14, 2022 | Dec 20, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 4, 2022 | Dec 20, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2022 | — |
| DEF 14A | Proxy statement | Apr 1, 2022 | May 18, 2022 |
| DEFA14A | Additional proxy material | May 19, 2021 | — |
| DEFA14A | Additional proxy material | Apr 6, 2021 | — |
| DEF 14A | Proxy statement | Apr 6, 2021 | Apr 6, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 26, 2021 | Mar 26, 2021 |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | Apr 9, 2020 |
| DEFA14A | Additional proxy material | Apr 10, 2019 | — |
| DEF 14A | Proxy statement | Apr 10, 2019 | Apr 10, 2019 |
| DEF 14A | Proxy statement | Apr 13, 2018 | Apr 13, 2018 |
| DEF 14A | Proxy statement | Apr 10, 2017 | Apr 10, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2017 | Mar 31, 2017 |
| DEF 14A | Proxy statement | Apr 15, 2016 | May 26, 2016 |
| DEFA14A | Additional proxy material | Apr 28, 2015 | — |
| DEF 14A | Proxy statement | Apr 28, 2015 | May 28, 2015 |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp (until Jan 10, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.